Hepatitis C virus in blood donation

Lancet

Volumn 365, Issue 9456, 2005, Pages 276-278

  Allain, Jean Pierre ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD DONOR; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOBLOTTING; LABORATORY DIAGNOSIS; NOTE; PRIORITY JOURNAL; SCREENING TEST;

EID: 12344326784     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)70165-3     Document Type: Note

References (6)

1. Lauer GM, Walker BD. Hepatitis C infection. N Engl J Med. 345:2001;41-52
2. Takaki A, Weise M, Maertens G, et al. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med. 6:2000;578-582
3. Kenny-Walsh E, for the Irish Hepatology Research Group. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. N Engl J Med 1999; 340: 1228-33.
4. Godkin AJ, Smith KJ, Willis A, et al. Naturally processed HLA class II peptides reveal highly conserved immunogenic flanking region sequence preferences that reflect antigen processing rather than peptide-MHC interactions. J Immunol. 166:2001;6720-6727
5. Candotti D, Temple J, Sarkodie F, Allain JP. Frequent recovery and broad genotype 2 diversity characterize hepatitis C virus infection in Ghana, West Africa. J Virol. 77:2003;7914-7923
6. Stramer SL. NAT update: where are we today? Dev Biol (Basel). 108:2002;41-56